Clinical Trials Directory

Trials / Unknown

UnknownNCT02599116

Gastrointestinal Microbiome Study of Appendiceal Cancer

A Cohort Study of the Gastrointestinal Microbiome in Appendiceal Cancer With Peritoneal Spread

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
24 (estimated)
Sponsor
Mercy Medical Center · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study analyzes the gastrointestinal microbiome of appendiceal cancer patients with peritoneal spread scheduled to undergo cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). Participants will provide fecal samples pre- and post-operatively.

Detailed description

Analysis of the human microbiome is an attempt to define how changes in the human microbiome are associated with health or disease. Eligible participants scheduled to undergo cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) for appendiceal cancer will provide fecal samples pre- and post-operatively. Investigators will analyze potential changes in the gastrointestinal microbiome and make comparisons to an age-matched healthy sample.

Conditions

Interventions

TypeNameDescription
OTHERBio-specimen collectionCollection of bio-specimens (fecal sample) at 3 different time points One pre-operative collection, Two post-operative collections
OTHERQuestionnaireCompletion of lifestyle and food questionnaires (2) at each bio-specimen collection timepoint

Timeline

Start date
2015-12-01
Primary completion
2024-12-01
Completion
2024-12-01
First posted
2015-11-06
Last updated
2023-03-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02599116. Inclusion in this directory is not an endorsement.